Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980795 · ClinicalTrials.gov registry record · NA
Exercise in Peritoneal Dialysis Patients (PDEX)
A NA study of Kidney Failure, Chronic and Peritoneal Dialysis, sponsored by Satellite Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT03980795: Completed NA study of Kidney Failure, Chronic and Peritoneal Dialysis, sponsored by Satellite Healthcare.
NCT03980795 is a NA study of Kidney Failure, Chronic and Peritoneal Dialysis that has completed, run by Satellite Healthcare. The registered enrollment target is 36 participants, below the 331-participant average among 23 other Kidney Failure, Chronic trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03980795, a NA study of Kidney Failure, Chronic and Peritoneal Dialysis, has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with end-stage kidney disease (ESKD) receiving peritoneal dialysis (PD) are physically inactive, resulting in poor physical function and reduced quality of life. The aim of this pilot trial was to test the study feasibility of a combined resistance and cardiovascular exercise program (recruitment and retention rates) and report adherence and adverse events. The intervention (I) group received monthly exercise physiologist consultations, exercise prescription (resistance and aerobic exercise program using exercise bands) and weekly phone calls over 12 weeks. Control (C) group received normal care. Feasibility outcomes were exercise adherence rates and adverse events. Secondary measures included physical function measures and patient-reported outcome measures (PROMs)
Primary Outcome
The number of patients safely completing the study relative to the sampling frame
Conditions Studied
Interventions
- OTHER Exercise Program
Study Locations (1)
California
- Satellite Wellbound Sacramento - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-03-30 |
| Phase | NA |
What the finished NCT03980795 record still lists
NCT03980795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 331-participant average among 23 other Kidney Failure, Chronic trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Kidney Failure, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Exercise Program is the first listed.
NCT03980795 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03980795 about?
NCT03980795 is a clinical study titled "Exercise in Peritoneal Dialysis Patients (PDEX)". Patients with end-stage kidney disease (ESKD) receiving peritoneal dialysis (PD) are physically inactive, resulting in poor physical function and reduced quality of life. The aim of this pilot trial was to test the study feasibility of a combined resistance and cardiovascular exercise program (recru...
What is the current status of trial NCT03980795?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2018-10-01. Estimated completion is 2019-03-30.
What conditions does trial NCT03980795 study?
This clinical trial studies the following conditions: Kidney Failure, Chronic, Peritoneal Dialysis.
What interventions are being tested in trial NCT03980795?
The interventions under investigation include: Exercise Program (OTHER).
Who is sponsoring clinical trial NCT03980795?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03980795 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Failure, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03980795's enrollment target sits among peer trials
36 16th of 23 higher than 8 of 23 other Kidney Failure, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Failure, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
COMPLETED · NA
-
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
COMPLETED · NA
-
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
COMPLETED · NA
-
Multidisciplinary Inpatient Palliative Care Intervention
COMPLETED · NA
-
Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes
COMPLETED · NA
-
Resistance Training and Diet in Patients With Chronic Renal Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI